158 related articles for article (PubMed ID: 26060496)
1. Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature.
Yang J; Zhang J; Xu Q; Sheng GP; Weng WW; Dong MJ
Int J Endocrinol; 2015; 2015():934726. PubMed ID: 26060496
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
[TBL] [Abstract][Full Text] [Related]
3. A Report of Three Girls with Antithyroid Drug-Induced Agranulocytosis; Retrospective Analysis of 18 Cases Aged 15 Years or Younger Reported between 1995 and 2009.
Minamitani K; Oikawa J; Wataki K; Kashima K; Hoshi M; Inomata H; Ota S
Clin Pediatr Endocrinol; 2011 Apr; 20(2):39-46. PubMed ID: 23926393
[TBL] [Abstract][Full Text] [Related]
4. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism.
Zhu D; Zhang S; Cao X; Xia Q; Zhang Q; Deng D; Gao S; Yu H; Liu Y; Zhou H; Tao F; Sun X
Endocr Pract; 2021 Dec; 27(12):1183-1188. PubMed ID: 34216800
[TBL] [Abstract][Full Text] [Related]
5. Antithyroid Drug Side Effects in the Population and in Pregnancy.
Andersen SL; Olsen J; Laurberg P
J Clin Endocrinol Metab; 2016 Apr; 101(4):1606-14. PubMed ID: 26815881
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
[TBL] [Abstract][Full Text] [Related]
7. A patient with agranulocytosis following the discontinuation of methimazole treatment for 4 months: A case report.
Bai XS; Liu JH; Xiao SM
Exp Ther Med; 2014 Sep; 8(3):823-825. PubMed ID: 25120607
[TBL] [Abstract][Full Text] [Related]
8. Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case.
Üçler R; Atmaca M; Candar Ö; Alay M; Göy B; Kara E; Turan M; Demir Y
Case Rep Endocrinol; 2015; 2015():974524. PubMed ID: 26339512
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
[TBL] [Abstract][Full Text] [Related]
10. Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors.
Khine A; Dhillon K; Jo L; Wormser V; Naing S; Mishra S
AACE Clin Case Rep; 2022; 8(2):82-84. PubMed ID: 35415227
[TBL] [Abstract][Full Text] [Related]
11. Massive plasmacytosis with severe marrow suppression induced by methimazole in Graves' disease patients: case report and literature review.
Xiao F; Li C; You L; Qian W; Wei J
Int J Clin Exp Med; 2014; 7(10):3605-8. PubMed ID: 25419407
[TBL] [Abstract][Full Text] [Related]
12. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole.
Vilchez FJ; Torres I; Garcia-Valero A; López-Tinoco C; de Los Santos A; Aguilar-Diosdado M
Ann Pharmacother; 2006 Nov; 40(11):2059-63. PubMed ID: 17077174
[TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies.
Gomez-Peralta F; Velasco-Martínez P; Abreu C; Cepeda M; Fernández-Puente M
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29340156
[TBL] [Abstract][Full Text] [Related]
14. [Agranulocytosis and acute coronary syndrome in apathetic hyperthyroidism].
Ivović M; Radiojković B; Penezić Z; Stojković M; Tancić M; Vujović S; Bogdanović A; Drezgić M
Srp Arh Celok Lek; 2003; 131(5-6):249-53. PubMed ID: 14692133
[TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity and cutaneous reactions after antithyroid drug administration.
Otsuka F; Noh JY; Chino T; Shimizu T; Mukasa K; Ito K; Ito K; Taniyama M
Clin Endocrinol (Oxf); 2012 Aug; 77(2):310-5. PubMed ID: 22332800
[TBL] [Abstract][Full Text] [Related]
16. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
[TBL] [Abstract][Full Text] [Related]
17. Sudden onset agranulocytosis and hepatotoxicity after taking methimazole.
Yang J; Zhong J; Zhou LZ; Hong T; Xiao XH; Wen GB
Intern Med; 2012; 51(16):2189-92. PubMed ID: 22892501
[TBL] [Abstract][Full Text] [Related]
18. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole.
Jain K; Chakrapani M; Smitha K
Ann Afr Med; 2010; 9(2):102-4. PubMed ID: 20587933
[TBL] [Abstract][Full Text] [Related]
19. Methimazole-induced agranulocytosis in Japanese patients with Graves' disease.
Tamai H; Takaichi Y; Morita T; Komaki G; Matsubayashi S; Kuma K; Walter RM; Kumagai LF; Nagataki S
Clin Endocrinol (Oxf); 1989 May; 30(5):525-30. PubMed ID: 2605789
[TBL] [Abstract][Full Text] [Related]
20. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.
Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D
J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
